You are here

TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

Celebrex (Celecoxib) not withdrawn from Australian market

Related information

Media statement

9 December 2004

Australia's drugs regulator, the Therapeutic Goods Administration (TGA), is aware that a media statement issued by the Complementary Healthcare Council of Australia on 8 December 2004 states that the Therapeutic Goods Administration has required the withdrawal from the Australian market of celecoxib ("Celebrex").

THAT STATEMENT IS FALSE - THE TGA HAS NOT TAKEN ANY ACTION TO REMOVE CELECOXIB PRODUCTS FROM THE MARKET.

The fact that the Therapeutic Goods Administration is reviewing information about the safety of all the currently registered Cox-2 inhibitor drugs is mentioned in the December 2004 issue of the Australian Adverse Drug Reactions Bulletin. That review in no sense constitutes a withdrawal of any of these products from the Australian market.

John McEwen
Principal Medical Adviser
Therapeutic Goods Administration

Media Contact: Kay McNiece, 0412 132 585